Suppr超能文献

钙蛋白酶抑制作用会损害HepG2肝癌细胞中的糖原合成,而不会改变胰岛素信号传导。

Calpain inhibition impairs glycogen syntheses in HepG2 hepatoma cells without altering insulin signaling.

作者信息

Meier Markus, Klein Harald H, Kramer Jan, Drenckhan Maren, Schütt Morten

机构信息

Department of Internal Medicine I, University of Lübeck, Ratzeburger Allee 160, D- 23538 Lübeck, Germany.

出版信息

J Endocrinol. 2007 Apr;193(1):45-51. doi: 10.1677/joe.1.07087.

Abstract

Calpains are a family of non-lysosomal cytoplasmatic cysteine proteases. Since calpain 10 (CAPN10), a member of the calpain family of proteases, has been found to represent a putative diabetes susceptibility gene, it was argued that calpains may be involved in the development of type 2 diabetes. The functional role of calpains in insulin signaling and/or insulin action is, however, not clear. We investigated the effects of the calpains 1 and 2 inhibitor PD151746 on insulin signaling and insulin action in human hepatoma G2 cells (HepG2). HepG2 cells were incubated without (-PD) or with (+PD) 5.33 micromol/l PD151746 for different times and then stimulated with 100 nmol/l insulin for 0 (t(0)), 5 (t(5)), 15 (t(15)), 30 (t(30)), 45 (t(45)), and 60 (t(60)) min. After solubilization of the cells, insulin receptor kinase activity, tyrosine phosphorylation of insulin receptor substrate-1 (IRS-1), IRS-1-associated phosphatidylinositol-3 kinase (PI3-kinase), PI3-kinase activity, Thr(308) phosphorlyation of Akt, amount of protein tyrosine phosphatase-epsilon (PTPepsilon), and glycogen synthase activity were determined. Incubation with PD151746 resulted in a significant reduction of insulin-stimulated glycogen synthesis compared with cells not pre-incubated with the calpain inhibitor (-PD: t(0), 4.90 +/- 1.20%; t(5), 5.90 +/- 1.02%; t(15), 5.29 +/- 0.95%; t(30), 5.60 +/- 1.10%; t(45), 5.52 +/- 0.90%; t(60), 5.67 +/- 0.97%;+PD: t(0), 4.56 +/- 1.10%; t(5), 6.16 +/- 1.05%; t(15), 7.52 +/- 1.09%; t(30), 7.68 +/- 1.10%; t(45), 8.28 +/- 0.89%; t(60), 7.69 +/- 0.98%; P < 0.05). Incubation with PD151746 significantly increased the protein amount of PTPepsilon in the cells after 12 h (-PD: t(1), 0.85 +/- 0.18 RU (Relative unit); t(8), 0.87 +/- 0.18 RU; t(12), 0.9 +/- 0.13 RU; +PD: t(1), 0.92 +/- 0.21 RU; t(8), 1.1 +/- 0.15 RU; t(12), 1.34 +/- 0.16 RU; P < 0.05). Calpain inhibition with PD151746 had no effect on the insulin stimulation of the investigated insulin signaling parameters. These results in HepG2 cells suggest that calpains play a role in the hepatic regulation of insulin-stimulated glycogen synthesis independent of the PI3-kinase/Akt signaling pathway.

摘要

钙蛋白酶是一类非溶酶体细胞质半胱氨酸蛋白酶。由于已发现蛋白酶钙蛋白酶家族成员钙蛋白酶10(CAPN10)是一个假定的糖尿病易感基因,因此有人认为钙蛋白酶可能参与2型糖尿病的发生发展。然而,钙蛋白酶在胰岛素信号传导和/或胰岛素作用中的功能作用尚不清楚。我们研究了钙蛋白酶1和2抑制剂PD151746对人肝癌G2细胞(HepG2)中胰岛素信号传导和胰岛素作用的影响。将HepG2细胞在无(-PD)或含(+PD)5.33微摩尔/升PD151746的条件下孵育不同时间,然后用100纳摩尔/升胰岛素刺激0(t(0))、5(t(5))、15(t(15))、30(t(30))、45(t(45))和60(t(60))分钟。细胞溶解后,测定胰岛素受体激酶活性、胰岛素受体底物-1(IRS-1)的酪氨酸磷酸化、与IRS-1相关的磷脂酰肌醇-3激酶(PI3激酶)、PI3激酶活性、Akt的苏氨酸(Thr(308))磷酸化、蛋白酪氨酸磷酸酶ε(PTPε)的量以及糖原合酶活性。与未用钙蛋白酶抑制剂预孵育的细胞相比(-PD:t(0),4.90±1.20%;t(5),5.90±1.02%;t(15),5.29±0.95%;t(30),5.60±1.10%;t(45),5.52±0.90%;t(60),5.67±0.97%;+PD:t(0),4.56±1.10%;t(5),6.16±1.05%;t(15),7.52±1.09%;t(30),7.68±1.10%;t(45),8.28±0.89%;t(60),7.69±0.98%;P<0.05),用PD151746孵育导致胰岛素刺激的糖原合成显著减少。用PD151746孵育12小时后,细胞中PTPε的蛋白量显著增加(-PD:t(1),0.85±0.18相对单位(RU);t(8),0.87±0.18 RU;t(12),0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验